Stephanie R Keller, MD






Stephanie Keller, MD, is a Pediatric Neurologist at Children’s Healthcare of Atlanta and Associate Professor of pediatrics and neurology at Emory University School of Medicine. She serves as Medical Director of the Neurogenetic and Metabolic Disease Program, as well as Director of the Leukodystrophy Care Network Certified Center at Children’s.

Dr. Keller’s focus in child neurology has been on the care of children with rare metabolic and genetic diseases, specifically leukodystrophies. In 2013, she created the Neurogenetic and Metabolic Disease Clinic to evaluate children with developmental delay and treat children with known genetic and metabolic diseases with neurologic symptoms. In 2016, she created the Leukodystrophy Care Center, a multidisciplinary clinic that includes neurology, physiatry, physical therapy, social work and genetic counseling. This clinic became a Leukodystrophy Care Network Certified Center in 2016.

Dr. Kelly is also involved in teaching medical students, residents and advanced practice practitioners about pediatric neurology, in particular neurogenetic diseases. She has given multiple lectures at Emory University, as well as patient advocacy and provider meetings on a regional and national level.


Childrens Physician Group - Neurology

Center for Advanced Pediatrics, 1400 Tullie Road NE 4th Floor
Atlanta, GA 30329
Get Directions 404-785-5437

Childrens Physician Group - Neurology

410 Peachtree Pkwy, Suite 300
Cumming, GA 30041
Get Directions 404-785-5437

Focus of Practice

  • Pediatric neurology

Areas of Interest

  • Neurogenetic and metabolic disease
  • Leukodystrophies
  • Neurodegenerative disorders
  • Developmental delay
  • General pediatric neurology

Professional Affiliations

  • Child Neurology Society
  • American Academy of Neurology
  • American Academy of Pediatrics
  • Global Leukodystrophy Initiative

Research Interests

Dr. Keller’s research interests include clinical research on leukodystrophies and genetic disorders with neurologic symptoms. She has been a part of multiple publications on leukodystrophies, mitochondrial diseases and other genetic disorders. Dr. Keller is also part of the Global Leukodystrophy Initiative Clinical Trials Network (GLIA- CTN), which was funded by the National Institutes of Health (NIH) and enables multicenter research on leukodystrophies. Additionally, she is participating in clinical research with other centers in the Leukodystrophy Care Network.


Children's Healthcare of Atlanta to be part of network helping to fight rare genetic disease

Children's was recently designated as one of eight Leukodystrophy Care Network (LCN) Centers in the nation. Dr. Stephanie Keller discusses what the rare condition is and how Children's can help patients facing this challenging diagnosis lead their best lives.